| Product Name | MF | CAS | Details |
|---|
| (R)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-onehydrochloride | C19H31NO2Si | 1190363-45-1 | Details |
| tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate | C12H17BrN4O2 | 1454848-24-8 | Details |
| 1-(1-(1H-imidazole-1-carbonyl)piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one | C15H16N6O2 | 1373116-06-3 | Details |
| 4-chloro-3-nitrobenzonitrile | C7H3ClN2O2 | 939-80-0 | Details |
| 4-fluoro-2-nitrobenzeneamine | C6H5FN2O2 | 364-78-3 | Details |
| 5-Aminoisophthalic acid | C8H7NO4 | 99-31-0 | Details |
| 4-(piperidin-4-yl)morpholine | C9H18N2O | 53617-35-9 | Details |
| tert-butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl)propan-2-yl)-1H-indole-3-carboxylate | C25H27IN2O2 | 1256584-75-4 | Details |
| Alectinib | C30H34N4O2 | 1256580-46-7 | Details |
| 2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid | C12H15IO2 | 1256584-73-2 | Details |
| 2-(4-ethylphenyl)-2-Methylpropanoic acid | C12H16O2 | 1247119-83-0 | Details |
| Pemigatinib | C24H27F2N5O4 | 1513857-77-6 | Details |
| Dimethyl 5-nitroisophthalate | C10H9NO6 | 13290-96-5 | Details |
| 2,6-difluoro-3,5-diMethoxybenzenamine | C8H9F2NO2 | 651734-54-2 | Details |
| 1H-Pyrrolo[2,3-b]pyridine-5-carboxaldehyde, 4-chloro-2-(4-morpholinylmethyl)-1-(phenylsulfonyl)- | C19H18ClN3O4S | 2382664-60-8 | Details |
| 9-ethyl-6,6-diMethyl-8-(4-Morpholinopiperidin-1-yl)-11-oxo-5a,6,11,11a-tetrahydro-5H-benzo[b]carbazole-3-carbonitrile hydrochloride | C30H35ClN4O2 | 1256589-74-8 | Details |
| 2,6-dichloro-3-nitro-4-aminopyridine | C5H3Cl2N3O2 | 2897-43-0 | Details |
| 1-methyl-3-((methylamino)methyl)-1H-pyrazole-5-carbonitrile HCl | C7H11ClN4 | 1643141-20-1 | Details |
| 7,8-dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione | C10H9NO2 | 39713-40-1 | Details |
| 1-PROP-2-YN-1-YLPYRROLIDINE | C7H11NO | 5799-76-8 | Details |
| tert-butyl 2-(4-cyano-2-nitrophenyl)-4-(4-ethyl-3-iodophenyl)-4-methyl-3-oxopentanoate | C25H27IN2O5 | 2287185-55-9 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||